Christophe Legrand

High Risk of Anal and Rectal Cancer in Patients With Anal and/or Perianal Crohn’s Disease

Laurent Beaugerie, Fabrice Carrat, Stéphane Nahon et al. · Clinical Gastroenterology and Hepatology · 2017 · 120 citations · Full text

Gastrointestinal Oncology, Medicine, Gastroenterology +8

Anti-CTLA-4 and anti-PD-1 immunotherapies repress tumor progression in preclinical breast and colon model with independent regulatory T cells response

Tristan Rupp, Laurie Genest, David Babin et al. · Translational Oncology · 2022 · 57 citations · Full text

Therapeutic potential of Fingolimod in triple negative breast cancer preclinical models

Tristan Rupp, Océane Pelouin, Laurie Genest et al. · Translational Oncology · 2020 · 26 citations · Full text

A Face-To-Face Comparison of Tumor Chicken Chorioallantoic Membrane (TCAM) In Ovo with Murine Models for Early Evaluation of Cancer Therapy and Early Drug Toxicity

Tristan Rupp, Christophe Legrand, Marion Hunault et al. · Cancers · 2022 · 12 citations · Full text

Whole‐Cell Configuration of the Patch‐Clamp Technique in the hERG Channel Assay to Predict the Ability of a Compound to Prolong QT Interval

Sonia Goineau, Christophe Legrand, Guillaume Froget · Current Protocols in Pharmacology · 2012 · 11 citations

Herg Channel, Pharmacotherapy, Biomedical Engineering +17